Nerve Stimulation Therapy (NST) for Urinary Incontinence

Nerve stimulation therapy, or percutaneous tibial nerve stimulation (PTNS), is a treatment for people who suffer from an overactive bladder. NST have provided patients with very positive results. For those who have tried exercises or medications with undesired results, this alternative can be a great solution. This non-surgical therapy stimulates the pelvic muscles, which are in charge of the expansion and contraction of the urethra. NST helps people to improve bladder control and to prevent urinary frequency.

Patients who have tried NST have experienced a significant reduction of incontinence and leakage episodes, over 50% according to studies.

It is also important to know that besides being an effective treatment with no report of side effects, it is also FDA (Food and Drug Administration) approved.

Nerve stimulation therapy is recommended for people with:

    • Diurnal and nocturnal enuresis

    • Urinary urgency and high frequency

    • Accidental leakage

    • Incontinence

Nerve stimulation therapy is a minimally invasive treatment that sends mild electric impulses to the pelvic nerves to stimulate the contractions and expansion of the bladder (urethral sphincter muscles) and is usually performed at an outpatient clinic.

What Is Used during Nerve Stimulation Therapy?

    • A stimulator A controlled device that will deliver the electrical impulses.

    • Needle electrodes, which will transfer the electrical pulses to the tibial nerve.

    • Adhesive electrode

    • Lead wire

As you can see, nerve stimulation therapy is a minimally invasive and a simple alternative when traditional medication is not working out.

How Does NST Work?

The stimulator sends electrical impulses through the lead wire to the needle electrode and the adhesive electrode. The needle will stimulate the tibial nerve directly and the adhesive electrode will stimulate the muscles.

How Long Does NTS or PTNS Treatment Take?

This treatment is initially performed for 30 minutes every week for 12 consecutive weeks. Then, depending on the evolution and results, the patient may still need occasional treatments. Further therapy will always depend on the patients’ outcomes and possible symptoms.

Leave a Reply

Your email address will not be published. Required fields are marked *